EUVIMEDEUVIMED entdecken
Open Access

Risk of Multiple Primary Cancers in Patients With Merkel Cell Carcinoma

Edward Eid, Nolan J Maloney, Zhuo Ran Cai, Lisa C Zaba, Nour Kibbi, Esther M John, Eleni Linos

JAMA Dermatology · 01.11.2023 · 159 (11) · 1248

DOI: 10.1001/jamadermatol.2023.2849 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Dermatology, erschienen am 01.11.2023. Verfasst von Edward Eid und 6 weiteren Autor:innen. Beteiligte Einrichtung: Program for Clinical Research and Technology, Department of Dermatology, Stanford University School of Medicine, Stanford, California. Hauptthemen laut MEDLINE: Skin Neoplasms, Carcinoma, Merkel Cell, Melanoma, Neoplasms, Second Primary. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance The risk of subsequent primary cancers after a diagnosis of cutaneous Merkel cell carcinoma (MCC) is not well established.

Objective

To evaluate the risk of subsequent primary cancers after the diagnosis of a first primary cutaneous MCC. Design, Setting, and Participants This cohort study analyzed data from 17 registries of the Surveillance, Epidemiology, and End Results (SEER) Program from January 1, 2000, to December 31, 2019. In all, 6146 patients diagnosed with a first primary cutaneous MCC were identified. Main Outcomes and Measures The primary outcome was the relative and absolute risks of subsequent primary cancers after the diagnosis of a first primary MCC, which were calculated using the standardized incidence ratio (SIR; ratio of observed to expected cases of subsequent cancer) and the excess risk (difference between observed and expected cases of subsequent cancer divided by the person-years at risk), respectively. Data were analyzed between January 1, 2000, and December 31, 2019.

Results

Of 6146 patients with a first primary MCC diagnosed at a median (IQR) age of 76 (66-83) years, 3713 (60.4%) were men, and the predominant race and ethnicity was non-Hispanic White (5491 individuals [89.3%]). Of these patients, 725 (11.8%) developed subsequent primary cancers, with an SIR of 1.28 (95% CI, 1.19-1.38) and excess risk of 57.25 per 10 000 person-years. For solid tumors after MCC, risk was elevated for cutaneous melanoma (SIR, 2.36 [95% CI, 1.85-2.97]; excess risk, 15.27 per 10 000 person-years) and papillary thyroid carcinoma (SIR, 5.26 [95% CI, 3.25-8.04]; excess risk, 6.16 per 10 000 person-years). For hematologic cancers after MCC, risk was increased for non-Hodgkin lymphoma (SIR, 2.62 [95% CI, 2.04-3.32]; excess risk, 15.48 per 10 000 person-years). Conclusions and Relevance This cohort study found that patients with MCC had an increased risk of subsequently developing solid and hematologic cancers. This increased risk may be associated with increased surveillance, treatment-related factors, or shared etiologies of the other cancers with MCC. Further studies exploring possible common etiological factors shared between MCC and other primary cancers are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsCarcinoma, Merkel CellMelanomaNeoplasms, Second PrimaryHematologic NeoplasmsNeoplasms, Multiple PrimaryMaleHumansAgedAged, 80 and overFemaleCohort StudiesIncidenceRisk FactorsSEER Program

Autor:innen und Institutionen

  • Program for Clinical Research and Technology, Department of Dermatology, Stanford University School of Medicine, Stanford, California.
  • Department of Dermatology, Stanford University School of Medicine, Stanford, California.
  • Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California.
  • Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California.
  • Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.

Förderung

  • NIAMS NIH HHS

Zitieren

APA

Eid, E., Maloney, N. J., Cai, Z. R., Zaba, L. C., Kibbi, N., John, E. M., & Linos, E. (2023). Risk of Multiple Primary Cancers in Patients With Merkel Cell Carcinoma. JAMA Dermatology, 159(11), 1248. https://doi.org/10.1001/jamadermatol.2023.2849

Vancouver

Eid E, Maloney NJ, Cai ZR, Zaba LC, Kibbi N, John EM, et al. Risk of Multiple Primary Cancers in Patients With Merkel Cell Carcinoma. JAMA Dermatology. 2023;159(11):1248. doi:10.1001/jamadermatol.2023.2849

BibTeX
@article{Eid2023,
  author = {Eid, Edward and Maloney, Nolan J and Cai, Zhuo Ran and Zaba, Lisa C and Kibbi, Nour and John, Esther M and Linos, Eleni},
  title = {Risk of Multiple Primary Cancers in Patients With Merkel Cell Carcinoma},
  journal = {JAMA Dermatology},
  year = {2023},
  volume = {159},
  number = {11},
  pages = {1248},
  doi = {10.1001/jamadermatol.2023.2849}
}
Kostenlos starten →